MALVERN, PA — Endo, Inc. (OTCQX: NDOI) has introduced the ADRENALIN® ready-to-use premixed intravenous (IV) bag, the first FDA-approved epinephrine premixed bag prepared directly by the ...
MALVERN, Pa., Dec. 2, 2024 /PRNewswire/ -- Endo, Inc. (OTCQX: NDOI) announced today the launch of its ADRENALIN® (epinephrine in 0.9% sodium chloride injection) ready-to-use premixed bag, the ...